- US-listed companies
- Dolby Laboratories, Inc.
- Balance sheet
Dolby Laboratories, Inc. (DLB) Balance sheet
Market cap
$5.1B
P/E ratio
20.2x
| 2010/09 | 2011/09 | 2012/09 | 2013/09 | 2014/09 | 2015/09 | 2016/09 | 2017/09 | 2018/09 | 2019/09 | 2020/09 | 2021/09 | 2022/09 | 2023/09 | 2024/09 | 2025/09 | |
| Cash and cash equivalents | 546 | 552 | 493 | 454 | 568 | 532 | 516 | 627 | 918 | 806 | 1,080 | 1,233 | 628 | 818 | 578 | 793 |
| Total cash & short-term investments | 546 | 552 | 493 | 454 | 568 | 532 | 516 | 627 | 918 | 806 | 1,080 | 1,233 | 628 | 818 | 578 | 793 |
| Accounts receivable, net | 54 | 62 | 43 | 97 | 86 | 102 | 76 | 74 | 137 | 189 | 180 | 233 | 244 | 262 | 315 | 331 |
| Inventories | 28 | 26 | 17 | 10 | 9 | 14 | 16 | 25 | 26 | 32 | 26 | 11 | 24 | 36 | 34 | 30 |
| Total current assets | 1,060 | 1,159 | 970 | 813 | 1,006 | 918 | 760 | 1,011 | 1,302 | 1,382 | 1,547 | 1,760 | 1,311 | 1,488 | 1,194 | 1,388 |
| Property, plant and equipment, net | 94 | 117 | 255 | 243 | 290 | 403 | 444 | 485 | 514 | 537 | 542 | 534 | 513 | 482 | 479 | 471 |
| Marketable securities, non-current | 191 | 273 | 362 | 306 | 296 | 321 | 394 | 314 | 188 | 180 | 52 | 63 | 103 | 98 | 89 | 80 |
| Total assets | 1,712 | 1,884 | 1,961 | 1,738 | 1,984 | 2,133 | 2,310 | 2,534 | 2,659 | 2,822 | 2,917 | 3,106 | 2,690 | 2,980 | 3,110 | 3,228 |
| Accounts payable | 4 | 11 | 15 | 11 | 16 | 21 | 18 | 14 | 22 | 15 | 13 | 18 | 14 | 21 | 17 | 18 |
| Total current liabilities | 166 | 159 | 157 | 173 | 189 | 210 | 213 | 246 | 272 | 307 | 267 | 316 | 278 | 422 | 418 | 438 |
| Total liabilities | 217 | 199 | 218 | 238 | 252 | 317 | 331 | 390 | 463 | 509 | 479 | 501 | 439 | 608 | 623 | 596 |
| Retained earnings | 1,136 | 1,445 | 1,709 | 1,454 | 1,660 | 1,801 | 1,938 | 2,083 | 2,139 | 2,328 | 2,443 | 2,608 | 2,298 | 2,392 | 2,496 | 2,635 |
| Stockholders' equity | 1,495 | 1,685 | 1,743 | 1,500 | 1,732 | 1,816 | 1,979 | 2,144 | 2,196 | 2,313 | 2,438 | 2,604 | 2,251 | 2,372 | 2,487 | 2,632 |
| Working capital |